Levitra (Vardenafil, BAY38-9456)
DrugTreatment according to US PI
NCT Number: NCT00663598
Collect data on safety, efficacy, and subject acceptance of vardenafil treatment under daily life conditions in a large number of subjects with erectile dysfunction (ED)
Looking for future studies?
Notify Me18 year and older
Male
Interventional
Phase 4
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Treatment according to US PI
Time frame: 8 weeks
Time frame: 8 weeks
Time frame: 8 weeks
Time frame: 8 weeks
Bayer
Industry
REALISE Levitra® - Real Life Safety and Efficacy of Levitra
Acronym: REALISE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07715448
Benign Prostatic Hyperplasia, Ejaculatory Dysfunction
Banī Suwayf, Beni Suef Governorate, Egypt
View Trial DetailsNCT06805513
Erectile Dysfunction, Genital Diseases
Salt Lake City, Utah, United States
View Trial DetailsNCT07692867
Erectile Dysfunction, Genital Diseases
Beijing, China
View Trial DetailsNCT07460167
Erectile Dysfunction, Genital Diseases
Qina, Egypt
View Trial Details